Vanguard Total World Stock ETF(VT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

VT Vanguard Total World Stock ETF

Post-Market Trading 11-21 16:28:25 EST

120.07

+0.57

+0.48%

盘后120.44

+0.37+0.31%

16:26 EST

High120.29	Low119.15	Vol992.46K
Open119.89	D1 Closing119.50	Amplitude0.96%
Mkt Cap41.43B	Tradable Cap41.43B	Total Shares345.03M
T/O118.96M	T/O Rate0.29%	Tradable Shares345.03M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"VT","market":"US","secType":"STK","nameCN":"Vanguard Total World Stock ETF","latestPrice":120.07,"timestamp":1732222800000,"preClose":119.5,"halted":0,"volume":992457,"hourTrading":{"tag":"盘后","latestPrice":120.44,"preClose":120.07,"latestTime":"16:26 EST","volume":3625,"amount":435260.220625,"timestamp":1732224382487},"delay":0,"floatShares":345032902,"shares":345032902,"eps":0,"marketStatus":"Post-Market Trading","change":0.57,"latestTime":"11-21 16:28:25 EST","open":119.89,"high":120.29,"low":119.145,"amount":118962575.25561,"amplitude":0.009582,"askPrice":121.1,"askSize":1,"bidPrice":119.5,"bidSize":90,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1732237200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":119.5,"sharesOutstanding":345032902,"nav":119.49,"aum":41227981459.98,"bidAskSpread":0.000114,"preHourTrading":{"tag":"盘前","latestPrice":120,"preClose":119.5,"latestTime":"09:27 EST","volume":1193,"amount":142099.86440999998,"timestamp":1732199262879},"postHourTrading":{"tag":"盘后","latestPrice":120.44,"preClose":120.07,"latestTime":"16:26 EST","volume":3625,"amount":435260.220625,"timestamp":1732224382487},"volumeRatio":0.649509,"impliedVol":0.0443,"impliedVolPercentile":0.0159},"requestUrl":"/m/hq/s/VT","defaultTab":"news","newsList":[{"id":"2484627329","title":"iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2484627329","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484627329?lang=en_us&edition=fundamental","pubTime":"2024-11-18 21:15","pubTimestamp":1731935700,"startTime":"0","endTime":"0","summary":"Five new studies span three focus areas for LTCM devices: digital engagement and patient satisfaction, arrhythmia patterns during sleep and activity, and the potential health care resource and economi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/18/2982765/0/en/iRhythm-Data-Presented-at-the-American-Heart-Association-2024-Scientific-Sessions-Reinforce-Clinical-and-Health-Economic-Value-of-Zio-Long-Term-Continuous-Monitoring.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","OR","VT","BK4588","BK4017","BK4107","BK4563","IRTC","BK4117","BK4082","AFG"],"gpt_icon":0},{"id":"2484612205","title":"VT Holdings Achieves Record Revenue and Profit Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2484612205","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484612205?lang=en_us&edition=fundamental","pubTime":"2024-11-18 15:24","pubTimestamp":1731914696,"startTime":"0","endTime":"0","summary":"VT Holdings Co., Ltd. (JP:7593) has released an update. VT Holdings Co., Ltd. reported a record high revenue increase of 17.3% year-over-year for t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vt-holdings-achieves-record-revenue-and-profit-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vt-holdings-achieves-record-revenue-and-profit-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VT"],"gpt_icon":0},{"id":"2483533225","title":"Adagio Medical Reports Third Quarter 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483533225","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483533225?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:01","pubTimestamp":1731618060,"startTime":"0","endTime":"0","summary":"LAGUNA HILLS, Calif., November 14, 2024----Adagio Medical Holdings, Inc. , a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced, today provided business updates for third quarter ended September 30, 2024.In October 2024, announced first procedures performed in the FULCRUM-VT pivotal study. The study will enroll 206 patients with both ischemic and non-ischemic disease at 20 US and Canadian centers. The results of the study will be used to support FDA premarket approval  for Adagio’s VT Cryoablation System for endocardial ablation of scar-mediated VT.In October 2024, at the 19th Annual International VT Symposium, presented the one-year follow-up data from the European Cryocure-VT study, demonstrating persistent reduction in VT burden and persistent reduction in use of anti-arrhythmic medication; investigators also reported low rates of Heart Failure- and VT-related hospitalizations.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adagio-medical-reports-third-quarter-210100468.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","ADGM","VT","BK4082","BK4585"],"gpt_icon":0},{"id":"2482793022","title":"Dr Boreham’s Crucible: Transforming the cardiac ablation market takes ticker… and time","url":"https://stock-news.laohu8.com/highlight/detail?id=2482793022","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482793022?lang=en_us&edition=fundamental","pubTime":"2024-11-12 04:00","pubTimestamp":1731355222,"startTime":"0","endTime":"0","summary":"Most biotechs savour the moment when they chalk up their first sales, but Imricor Medical Systems  founder and CEO Steve Wedan almost regrets the company is generating small initial revenues in Europe from its novel ablation catheters.“I almost wish we weren’t, because there are companies in our space that aren’t yet commercial and have a valuation three times ours,” he says.Ah!","market":"hk","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/09/boreham-csl-1200_x_675-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/09/boreham-csl-1200_x_675-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stockhead.com.au/health/dr-borehams-crucible-transforming-the-cardiac-ablation-market-takes-ticker-and-time/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["BK4187","LU0511384066.AUD","IE00BVYPNW00.USD","LU0943347566.SGD","LU0689626769.HKD","LU2756315664.SGD","BK4501","LU0820561818.USD","IE00BGHQF631.EUR","LU0124676726.USD","LU1988902786.USD","LU1093756325.SGD","LU2756315318.SGD","LU1366333091.USD","LU1551013425.SGD","LU1261432733.SGD","LU1551013342.USD","LU0354030511.USD","LU1064131342.USD","LU0868494617.USD","GE","BK4206","LU2264538146.SGD","AFL","LU0354030438.USD","LU1093756168.USD","LU0289739343.SGD","LU0157215616.USD","LU0820561909.HKD","LU0149725797.USD","LU0640476718.USD","LU0289961442.SGD","BK4162","LU0069063385.USD","IE00B42XCP33.USD","LU0689472784.USD","BK4585","LU0057025933.USD","BK4566","VT","IE00BVYPNV92.GBP","LU1280957306.USD","IE00BDGV0183.EUR","LU0820562030.AUD","BK4588","IE00B3PB1722.GBP","LU0472753341.HKD"],"gpt_icon":0},{"id":"2479744426","title":"VT Holdings Strengthens Corporate Governance and Business Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2479744426","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479744426?lang=en_us&edition=fundamental","pubTime":"2024-10-31 12:53","pubTimestamp":1730350409,"startTime":"0","endTime":"0","summary":"VT Holdings Co., Ltd. (JP:7593) has released an update. VT Holdings Co., Ltd. has implemented a holding company system to enhance business agility ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vt-holdings-strengthens-corporate-governance-and-business-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vt-holdings-strengthens-corporate-governance-and-business-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VT","BK4588","BK4585"],"gpt_icon":0},{"id":"2479790132","title":"Basement to Breakthrough: Imricor transforms heart treatment with MRI","url":"https://stock-news.laohu8.com/highlight/detail?id=2479790132","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479790132?lang=en_us&edition=fundamental","pubTime":"2024-10-31 09:55","pubTimestamp":1730339725,"startTime":"0","endTime":"0","summary":"Imricor co-founder Steve Wedan says the company’s work over almost two decades is coming together. Company has developed the world’s only MRI-compatible devices for cardiac ablation procedures. Imricor on track for US-FDA approval for atrial flutter in 2025, with approval received in Europe","market":"us","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/10/2024-29-10-IMR-NM-1200_x_675-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/10/2024-29-10-IMR-NM-1200_x_675-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stockhead.com.au/health/basement-to-breakthrough-imricor-transforms-heart-treatment-with-mri/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["VT","BK4585","BK4588"],"gpt_icon":0},{"id":"2478699820","title":"A new paradigm in electrophysiology: Medtronic receives FDA approval of Affera™ Mapping and Ablation System and Sphere-9™ Catheter","url":"https://stock-news.laohu8.com/highlight/detail?id=2478699820","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478699820?lang=en_us&edition=fundamental","pubTime":"2024-10-25 04:33","pubTimestamp":1729801980,"startTime":"0","endTime":"0","summary":"First-of-its-kind, all-in-one HD-mapping and dual energy  ablation catheter. Now with two pulsed field ablation  offerings and a portfolio of electrophysiology solutions, Medtronic is shaping the future of arrythmia treatment today. GALWAY, Ireland, Oct. 24, 2024 /PRNewswire/ --Medtronic plc , a global leader in healthcare technology, today announced United States Food and Drug Administration  approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density  mapping and pulsed field  and radiofrequency  ablation catheter for treatment of persistent atrial fibrillation  and for RF ablation of cavotricuspid isthmus  dependent atrial flutter.With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib. The PulseSelect Pulsed Field Ablation System, which was FDA approved in December 2023, offers physicians a safe, single-shot solution for pulmonary vein isolation  while the Affera Sphere-9 c","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/C6W0yp..bJuY5TXP5qpwJA--~B/aD00MDA7dz0yMzQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/fc061aae331d3f70c7a1ebb47b1ed785","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/C6W0yp..bJuY5TXP5qpwJA--~B/aD00MDA7dz0yMzQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/fc061aae331d3f70c7a1ebb47b1ed785"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/paradigm-electrophysiology-medtronic-receives-fda-203300768.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/paradigm-electrophysiology-medtronic-receives-fda-203300768.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IDE","LU0976567544.SGD","LU1989764748.USD","LU1989771016.USD","BK4585","LU0211326755.USD","LU0868494617.USD","BK4082","LU2089284900.SGD","BK4533","BK4566","LU1496350502.SGD","IE00BZ1G4Q59.USD","LU0234572021.USD","BK4550","LU1551013425.SGD","RF","LU1291159041.SGD","LU1989764664.SGD","LU0868494708.USD","LU2089283258.USD","LU0354030511.USD","LU2756315318.SGD","LU1093756325.SGD","LU0943347566.SGD","BK4588","LU1914381329.SGD","LU1496350171.SGD","LU1989772923.USD","HD","IE00B3T34201.USD","LU0072461881.USD","LU2271345857.HKD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","IE00BQXX3F31.USD","LU0211331839.USD","LU1162221912.USD","LU2111349929.HKD","LU2756315664.SGD","BK4083","LU0820562030.AUD","PVI","LU1551013342.USD","LU1778281490.HKD","LU0208291251.USD","LU0320765489.SGD","VT","MDT"],"gpt_icon":0},{"id":"2477163818","title":"Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System","url":"https://stock-news.laohu8.com/highlight/detail?id=2477163818","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477163818?lang=en_us&edition=fundamental","pubTime":"2024-10-24 20:30","pubTimestamp":1729773000,"startTime":"0","endTime":"0","summary":"LAGUNA HILLS, Calif., October 24, 2024----Adagio Medical Holdings, Inc. , a leading innovator in catheter ablation technologies, today announced the completion of the first procedures in FULCRUM-VT U.S. Food and Drug Administration  Pivotal IDE study of Adagio’s VT Cryoablation System. Procedures were performed by Professor William G. Stevenson, MD, at Vanderbilt University Medical Center in Nashville, TN and Dr. J. David Burkhardt at Texas Cardiac Arrhythmias Institute  at Austin, TX.FULCRUM-VT  is a prospective, multi-center, open-label, single-arm study, enrolling 206 patients with structural heart disease of both ischemic and non-ischemic cardiomyopathy, indicated for catheter ablation of drug refractory ventricular tachycardia  in accordance with current treatment guidelines. The results of the study will be used to obtain FDA premarket approval  for Adagio’s VT Cryoablation System with the vCLAS cryoablation catheter with industry broadest indication for purely endocardial ablati","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adagio-medical-announces-completion-first-123000155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","VT","LU2346227817.USD","BK4588","LU2637428348.USD","BK4082","BK4208","ADGM","CMS"],"gpt_icon":0},{"id":"2477857064","title":"Catheter Precision Announces Clinical Publication of Non-Invasive Stereotactic Radioablation Using VIVO","url":"https://stock-news.laohu8.com/highlight/detail?id=2477857064","media":"ACCESSWIRE","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477857064?lang=en_us&edition=fundamental","pubTime":"2024-10-21 20:30","pubTimestamp":1729513800,"startTime":"0","endTime":"0","summary":"FORT MILL, SC / ACCESSWIRE / October 21, 2024 / Catheter Precision, Inc. , a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced a new publication in the October 2024 issue of HeartRhythm Case Reports.This recent publication focuses on a patient procedure in which a novel, non-invasive ablation technique known as stereotactic radioablation  was used. STAR utilizes external photon beams, similar to those used to treat cancer, to non-invasively target and ablate areas of the heart responsible for the arrhythmia. Though new, and not widely available, this technique has proven to have success in patients that have not responded to traditional ablation for ventricular tachycardia. For non-invasive ablation to be successful, pre-procedural information is required to define the target location for ablation. VIVO can provide such information and during this procedure VIVO was able to identify a more precise ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/zBErNUgIE5AgcCTM6uti_Q--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/9a9dac32fe2a671250ae925a6d00bec0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/zBErNUgIE5AgcCTM6uti_Q--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/9a9dac32fe2a671250ae925a6d00bec0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/catheter-precision-announces-clinical-publication-123000206.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","HF","BK4198","USA","VTAK","BK4082","VIVO","VT","BK4588"],"gpt_icon":1},{"id":"2475294835","title":"Is Goldman Sachs ActiveBeta World Low Vol Plus Equity ETF (GLOV) a Strong ETF Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2475294835","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475294835?lang=en_us&edition=fundamental","pubTime":"2024-10-16 18:20","pubTimestamp":1729074006,"startTime":"0","endTime":"0","summary":"Launched on 03/15/2022, the Goldman Sachs ActiveBeta World Low Vol Plus Equity ETF  is a smart beta exchange traded fund offering broad exposure to the Broad Developed World ETFs category of the market.Products that are based on market cap weighted indexes, which are strategies designed to reflect a specific market segment or the market as a whole, have traditionally dominated the ETF industry.Market cap weighted indexes offer a low-cost, convenient, and transparent way of replicating market returns, and are a good option for investors who believe in market efficiency.Managed by Goldman Sachs Funds, GLOV has amassed assets over $1.03 billion, making it one of the average sized ETFs in the Broad Developed World ETFs. This particular fund seeks to match the performance of the GOLDMAN SACHS ACTBT WORLD LW VL PL EQ ID before fees and expenses.The Goldman Sachs ActiveBeta World Low Vol Plus Equity Index delivers exposure to large and mid-capitalization equity securities of developed market ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/OL7xfT5pzuzwP2wxb1pcSw--~B/aD02MjU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7ea641b46fe75c0a913349e5e610d6a2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/OL7xfT5pzuzwP2wxb1pcSw--~B/aD02MjU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7ea641b46fe75c0a913349e5e610d6a2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/goldman-sachs-activebeta-world-low-102006875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4141","BK4550","BK4571","IE00B1XK9C88.USD","LU0048584097.USD","LU1668664300.SGD","IE00BFXG0V08.USD","FDN","BK4553","IE00BJJMRX11.SGD","BK4581","IE00B3M56506.USD","VT","BK4559","BK4575","BK4577","BK4538","AAPL","IE00BBT3K403.USD","BK4554","3NVD.UK","GB00BDT5M118.USD","GS","BK4543","GSBD","MSFT","IE0034235188.USD","GLOV","BK4532","BK4592","BK4170","IE0004445015.USD","ACWI","BK4579","IE00BDCRKT87.USD","IE0004445239.USD","BK4548","BK4549","2NVD.UK","IE00B4YYXB79.USD","LU0061474960.USD","NVDA","BK4534","HK0000320223.HKD","BK4567","IE00BFXG1179.USD","IE00BJJMRY28.SGD","L","IE0034235295.USD","BK4533","LU0057025933.USD","HK0000320264.USD"],"gpt_icon":1},{"id":"2475388224","title":"Imricor eyes worldwide expansion with progress on US and EU regulatory approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2475388224","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475388224?lang=en_us&edition=fundamental","pubTime":"2024-10-14 12:23","pubTimestamp":1728879831,"startTime":"0","endTime":"0","summary":"Imricor’s US FDA review for its first premarket approval module has been successfully completed ahead of schedule.In summary the audit results were positive, and the company would be recommended for certification to manufacture these products under the new, more stringent MDR regime.Earlier this year, the MDR technical review of the Vision-MR Ablation Catheter 2.0 was completed successfully, meaning only the final certification was required to start manufacturing and selling the device.The new 2.0 catheter would be phased in to replace the original Vision-MR Ablation Catheter in the market. Along with the new 2.0 catheter, IMR’s Advantage-MR system must also be approved under MDR.The first round of that technical review is complete, with Imricor receiving positive feedback on the overall technical documentation from TV SD.The company said it would respond to questions by October 18, and the commercial launch of the new MDR Advantage-MR system was expected in Q1 2025, ahead of IMR’s ori","market":"hk","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/10/2023-14-10-IMR-NM-640x359.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/10/2023-14-10-IMR-NM-640x359.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stockhead.com.au/health/imricor-eyes-worldwide-expansion-with-progress-on-us-and-eu-regulatory-approval/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["BK4585","BK4156","BK4588","VT","PME","BK4212"],"gpt_icon":0},{"id":"2474974899","title":"Catheter Precision Scheduled to Attend the International Ventricular Tachycardia (VT) Symposium October 11 - 12 in New York City","url":"https://stock-news.laohu8.com/highlight/detail?id=2474974899","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474974899?lang=en_us&edition=fundamental","pubTime":"2024-10-10 20:30","pubTimestamp":1728563400,"startTime":"0","endTime":"0","summary":"FORT MILL, SC / ACCESSWIRE / October 10, 2024 / Catheter Precision, Inc. , a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced their attendance at the 19th annual International VT Symposium on October 11 and 12 in New York City.The VT Symposium is hosted and coordinated by the Hospital at the University of Pennsylvania and Mount Sinai Hospital and focuses on new information and management strategies used for the care of ventricular arrhythmias in various disease states, including nonpharmacological therapies such as implantable devices and catheter ablation techniques.\"The VT Symposium is one of the most important meetings that we attend each year\", said David Jenkins, CEO of Catheter Precision. \"This meeting provides a small, but targeted group of physicians that focus on treating ventricular arrhythmias. VIVO enables these physicians to better plan their ventricular ablation procedures, saving pr","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/zBErNUgIE5AgcCTM6uti_Q--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/9a9dac32fe2a671250ae925a6d00bec0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/zBErNUgIE5AgcCTM6uti_Q--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/9a9dac32fe2a671250ae925a6d00bec0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/catheter-precision-scheduled-attend-international-123000924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CHCO","BK4211","BK4585","BK4588","VT","VTAK","BK4082"],"gpt_icon":0},{"id":"2474120591","title":"ASX medical disruptors pioneering new diagnostics and cutting-edge procedures","url":"https://stock-news.laohu8.com/highlight/detail?id=2474120591","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474120591?lang=en_us&edition=fundamental","pubTime":"2024-10-10 04:30","pubTimestamp":1728505813,"startTime":"0","endTime":"0","summary":"New technologies are transforming healthcare and challenging traditional medical practices. Optiscan’s technology is about bringing pathologists and surgeons closer together in real time for faster diagnosis. Singular Health’s 3Dicom product translates and converts MRIs, CT and PET scans into 3D or virtual reality and extended reality  models","market":"us","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/10/1200-3-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/10/1200-3-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stockhead.com.au/health/asx-medical-disruptors-pioneering-new-diagnostics-and-cutting-edge-procedures/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["BK4585","BK4006","BK4588","VT","AMR"],"gpt_icon":0},{"id":"2472240843","title":"Is SPDR S&P Global Dividend ETF (WDIV) a Strong ETF Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2472240843","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472240843?lang=en_us&edition=fundamental","pubTime":"2024-10-01 18:20","pubTimestamp":1727778008,"startTime":"0","endTime":"0","summary":"Launched on 05/29/2013, the SPDR S&P Global Dividend ETF  is a smart beta exchange traded fund offering broad exposure to the World ETFs category of the market.For a long time now, the ETF industry has been flooded with products based on market capitalization weighted indexes, which are designed to represent the broader market or a particular market segment.Market cap weighted indexes offer a low-cost, convenient, and transparent way of replicating market returns, and are a good option for investors who believe in market efficiency.But, there are some investors who would rather invest in smart beta funds; these funds track non-cap weighted strategies, and are a strong option for those who prefer choosing great stocks in order to beat the market.Based on specific fundamental characteristics, or a combination of such, these indexes attempt to pick stocks that have a better chance of risk-return performance.The ETF has a beta of 0.83 and standard deviation of 13.55% for the trailing three","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d6hN0_BhikrNdWTnix6fng--~B/aD03NDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d6hN0_BhikrNdWTnix6fng--~B/aD03NDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/spdr-p-global-dividend-etf-102008893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MO","LU1989763005.USD","VT","SG9999014914.USD","LU0158827781.USD","SGXZ31699556.SGD","LU0097036916.USD","BK4534","LU2264538146.SGD","LU2210149790.SGD","LU1989772840.SGD","LU1496350171.SGD","SG9999014906.USD","SG9999018857.SGD","LU2271345857.HKD","LU1363072403.SGD","BK4075","LU1496350502.SGD","LU2023251221.USD","LU2764262908.HKD","SG9999014880.SGD","ACWI","LU0345774391.USD","WDIV","HIW","LU0158827948.USD","LU1989764748.USD","LU0985320562.USD","LU1064131342.USD","LU2720916845.USD","LU1804176565.USD","LU0354030511.USD","SG9999017495.SGD","LU1988902786.USD","BK4581","LU1989772923.USD","SG9999014898.SGD","LU2028103732.USD","LU0345774631.USD","SPGI","FDN","SG9999001077.SGD","SG9999018865.SGD","LU0342679015.USD","LU1989764664.SGD","BK4548","BK4194","LU2089283258.USD","LU2111349929.HKD","LU2210150020.SGD"],"gpt_icon":0},{"id":"2469120021","title":"HealthInvest 2024: The biotech sector looks in rude health, judging by these five ASX innovators","url":"https://stock-news.laohu8.com/highlight/detail?id=2469120021","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469120021?lang=en_us&edition=fundamental","pubTime":"2024-09-24 04:30","pubTimestamp":1727123458,"startTime":"0","endTime":"0","summary":"Stockhead joined with IR Department and Morgans for HealthInvest 2024 in Sydney last week. Imricor Medical Systems, Race Oncology, Clarity Pharmaceuticals, Percheron Therapeutics and ImpediMed all presented. Imricor Medical Systems Vice president of corporate strategy with Imricor, Nick Corkhill was first to grab the mic from the event’s hosts.Before joining IMR earlier this year, Corkill spent 15 years in asset management initially as an equity analyst at Perpetual Investments followed by portfolio manager at BlackRock and more recently Lennox Capital Future Leaders Fund.IMR is focused on development and manufacture of MRI compatible devices for performing a cardiac ablation, where a catheter is guided into the heart with the purpose of burning/ablating the tissue responsible for causing an arrhythmia .“An irregular heartbeat doesn’t sound that bad until you have it,” said Corkhill. “Arrhythmias are very common, to the point where one in four adults over the age of 75 are expected to ","market":"hk","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/09/GettyImages-1189926489-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/09/GettyImages-1189926489-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stockhead.com.au/health/healthinvest-2024-the-biotech-sector-looks-in-rude-health-judging-by-these-five-asx-innovators/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["PET","BK4192","VT","BK4588","BIS","BK4585"],"gpt_icon":0},{"id":"2469581141","title":"VT: Dollar Weakness And Lower Rates Are Tailwinds (Rating Upgrade)","url":"https://stock-news.laohu8.com/highlight/detail?id=2469581141","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469581141?lang=en_us&edition=fundamental","pubTime":"2024-09-23 11:59","pubTimestamp":1727063940,"startTime":"0","endTime":"0","summary":"Laurence Dutton Global stocks approach the fourth quarter with strong gains on the year. The Vanguard Total World Stock Index Fund (NYSEARCA:VT) is up 16% year to date through September 20, following significant appreciation in 2023. VT is essentially a cap-weighted mix","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1510979099/image_1510979099.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1510979099/image_1510979099.jpg"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4722605-vt-dollar-weakness-and-lower-rates-are-tailwinds-rating-upgrade","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_fund","symbols":["VT"],"gpt_icon":0},{"id":"2468426660","title":"ScoPo’s Powerplays: ASX health stocks fall but there’s ‘wind in the sails again’","url":"https://stock-news.laohu8.com/highlight/detail?id=2468426660","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468426660?lang=en_us&edition=fundamental","pubTime":"2024-09-20 13:37","pubTimestamp":1726810649,"startTime":"0","endTime":"0","summary":"ASX health stocks dropped 1.74% in the past five days, while the broader markets rose 1.55%. Power confident USFed’s 50 basis points cut in cash rate this week will bring more optimism to the sector. Morgans, investor relations firm IR Department and Stockhead teamed up to host HealthInvest 2024 in Sydney this week","market":"us","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/09/1200-10-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/09/1200-10-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stockhead.com.au/health/scopos-powerplays-asx-health-stocks-fall-but-wind-in-the-sails-again/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["VT","BK4585","BIS","BK4588"],"gpt_icon":0},{"id":"2466227043","title":"Cisco: Acquisition Of Splunk To Boost Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2466227043","media":"seekingalpha","labels":["Company Corporation","analysis"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466227043?lang=en_us&edition=fundamental","pubTime":"2024-09-12 21:05","pubTimestamp":1726146343,"startTime":"0","endTime":"0","summary":"Cisco's acquisition of Splunk, valued at $28 billion, is expected to enhance Cisco's gross margins and revenue growth despite a $5.74 billion premium paid on the acquisition.The deal will boost Cisco'","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/458975641/image_458975641.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/458975641/image_458975641.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4720675-cisco-acquisition-of-splunk-to-boost-growth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation,analysis","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["LU1992135399.USD","IE00B894F039.SGD","PT","IE0004091025.USD","BK4588","IE00BKVL7J92.USD","IE00B775H168.HKD","LU1585245621.USD","IE00BZ1G4Q59.USD","IE00BFXG1179.USD","IE00BK4W5M84.HKD","LU0731783394.SGD","SG9999002232.USD","IE00BDRTCR15.USD","IE00BJLML261.HKD","LU1244550221.USD","SG9999001440.SGD","SG9999002224.SGD","LU1720051017.SGD","LU0234572021.USD","LU1894683264.USD","LU1066053197.SGD","LU1430594728.SGD","IE00BFXG0V08.USD","VT","LU2023250504.SGD","LU2433249047.HKD","IE00BHPRN162.USD","LU1046421795.USD","BK4577","IE00BZ9MQY76.HKD","LU1169590202.USD","IE00BJTD4V19.USD","LU1506573853.SGD","LU2106854487.HKD","IE00B19Z8X17.USD","BK4581","BK4579","BK4587","LU1917777945.USD","SPLK","CSCO","IE00B19Z9Z06.USD","IE00BJTD4N35.SGD","IE00BK4W5L77.USD","IE00B5949003.HKD","LU0234570918.USD","IE00B3T34201.USD"],"gpt_icon":1},{"id":"2466421335","title":"ACWI: Global Stocks Face Seasonal Pressure, High-Teens P/E","url":"https://stock-news.laohu8.com/highlight/detail?id=2466421335","media":"seekingalpha","labels":["analysis"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466421335?lang=en_us&edition=fundamental","pubTime":"2024-09-11 13:12","pubTimestamp":1726031576,"startTime":"0","endTime":"0","summary":"I maintain a hold rating on ACWI due to its lukewarm valuation and anticipated near-term volatility, especially with bearish seasonal trends and technical signals.ACWI trades near 18x earnings, with 2","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1303046106/image_1303046106.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1303046106/image_1303046106.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4720340-acwi-global-stocks-face-seasonal-pressure-high-teens-pe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4588","BK4585","FDN","ACWI","BK4550","VT"],"gpt_icon":0},{"id":"2465494505","title":"Presentation at European Society of Cardiology Demonstrates VIVO Accuracy in Complex VT Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2465494505","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2465494505?lang=en_us&edition=fundamental","pubTime":"2024-09-05 21:00","pubTimestamp":1725541200,"startTime":"0","endTime":"0","summary":"FORT MILL, SC / ACCESSWIRE / September 5, 2024 / Catheter Precision, Inc.  today announced that at the recently held European Society of Cardiology  Symposium, interim results demonstrating the use of VIVO in localizing the site of origin of ventricular tachycardia  for patients with scar related re-entrant VT were presented. Additionally, the presentation showed the relationship to the relevant myocardial scar on cross-sectional imaging from the CT scan. The study, ongoing at the Warwick Medical School at the University Hospitals of Coventry and Warwickshire is ongoing with lead investigator Professor Tarv Dhanjal. The presentation was entitled \"Accuracy of a non-invasive mapping system for the localization of re-entrant VT site of origin and its relationship to myocardial scar on cross-sectional imaging\".","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/presentation-european-society-cardiology-demonstrates-130000654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4198","BK4585","BK4588","VT","VIVO","VTAK","BK4082"],"gpt_icon":1}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0069},{"period":"1month","weight":-0.0038},{"period":"3month","weight":0.0327},{"period":"6month","weight":0.0671},{"period":"1year","weight":0.2215},{"period":"ytd","weight":0.1615}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0118},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.1153},{"period":"1year","weight":0.3028},{"period":"ytd","weight":0.2423}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The fund employs an indexing investment approach designed to track the performance of the FTSE Global All Cap Index. The advisor attempts to sample the target index by investing all, or substantially all, of its assets in common stocks in the index and by holding a representative sample of securities that resembles the full index in terms of key risk factors and other characteristics.","yearOnYearQuotes":[{"month":1,"riseRate":0.4375,"avgChangeRate":0.000441},{"month":2,"riseRate":0.5625,"avgChangeRate":0.00331},{"month":3,"riseRate":0.6875,"avgChangeRate":0.011764},{"month":4,"riseRate":0.75,"avgChangeRate":0.019713},{"month":5,"riseRate":0.625,"avgChangeRate":-0.000515},{"month":6,"riseRate":0.4375,"avgChangeRate":-0.001056},{"month":7,"riseRate":0.764706,"avgChangeRate":0.027781},{"month":8,"riseRate":0.529412,"avgChangeRate":-0.006533},{"month":9,"riseRate":0.470588,"avgChangeRate":-0.01348},{"month":10,"riseRate":0.529412,"avgChangeRate":0.001016},{"month":11,"riseRate":0.705882,"avgChangeRate":0.020822},{"month":12,"riseRate":0.6875,"avgChangeRate":0.00516}],"exchange":"ARCA","name":"Vanguard Total World Stock ETF","nameEN":"Vanguard Total World Stock ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vanguard Total World Stock ETF(VT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Vanguard Total World Stock ETF(VT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Vanguard Total World Stock ETF,VT,Vanguard Total World Stock ETF股票,Vanguard Total World Stock ETF股票老虎,Vanguard Total World Stock ETF股票老虎国际,Vanguard Total World Stock ETF行情,Vanguard Total World Stock ETF股票行情,Vanguard Total World Stock ETF股价,Vanguard Total World Stock ETF股市,Vanguard Total World Stock ETF股票价格,Vanguard Total World Stock ETF股票交易,Vanguard Total World Stock ETF股票购买,Vanguard Total World Stock ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vanguard Total World Stock ETF(VT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Vanguard Total World Stock ETF(VT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}